Paid Clinical Trials in Everett, WA
As of August 2026, 72 paid clinical trials are recruiting in Everett, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Everett offers studies at sites including Providence Regional Cancer Partnership for conditions such as Bipolar I Disorder, Major Depressive Disorder, Schizophrenia, Bipolar Depression. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Everett
Trials by drug in Everett
Filter results
Newly added in Everett
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
66 clinical trials
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
C-Brace Prospective Registry
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Family Communications After Genetic Testing
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Top Research Study Locations in Everett
Researchers run research studies in Everett, WA at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Regional Cancer Partnership | Malignant Solid Neoplasm, Breast Cancer, Ovarian Carcinoma | 35 |
| Core Clinical Research | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 17 |
| Providence Regional Medical Center Everett | COVID-19, Central Line Associated Blood Stream Infections (CLABSI), Clostridoides Difficile Associated Disease | 6 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Alkermes Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Alkermes Investigator Site | Bipolar I Disorder, Schizophrenia | 1 |
| Cornerstone P&O | Lower Extremity, Pareses | 1 |
| Cornerstone Prosthetics and Orthotics | Lower Extremity Injuries | 1 |
| Local Institution - 0003 | Major Depressive Disorder | 1 |
| Local Institution - 0019 | Irritability Associated With Autism Spectrum Disorder | 1 |
| Local Institution - 0155 | Autism-Related Irritability, Schizophrenia | 1 |
| Providence Everett | Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III | 1 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 1 |
| Vanda Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Western Washington Medical Group | Cardiovascular Disease | 1 |
Active & Upcoming Studies in Everett (2026)
Recruiting trials in Everett grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Mental health & behavior (13 active studies)
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
Neurology & pain (3 active studies)
- Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine · Phase 3 · AbbVie
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) · Phase 3 · AbbVie
Vaccines (1 active study)
Diabetes & metabolic (1 active study)
Cardiovascular (1 active study)
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III · Endotronix, Inc.
Pediatric (1 active study)
Common conditions studied in Everett
- Bipolar I Disorder (7 active studies)
- Major Depressive Disorder (7 active studies)
- Schizophrenia (5 active studies)
- Bipolar Depression (3 active studies)
- Bipolar Disorder (3 active studies)
- Bipolar II Disorder (3 active studies)
Leading research sponsors in Everett
- SWOG Cancer Research Network
- AbbVie
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- Xenon Pharmaceuticals Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Everett?
There are approximately 72 recruiting clinical trials in Everett, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Everett pay participants?
Most recruiting trials in Everett compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Everett?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Everett?
The most common conditions under active study in Everett include Bipolar I Disorder (7), Major Depressive Disorder (7), Schizophrenia (5), Bipolar Depression (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Everett?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Everett on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Everett?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Everett?
Recruiting research sites in Everett include Providence Regional Cancer Partnership, Core Clinical Research, Providence Regional Medical Center Everett, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Everett right now?
The largest active categories in Everett are Cancer & tumors (24), Mental health & behavior (13), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.